FPT Retail (FRT) 9M2026: Revenue Up 33% to VND 48,273B, Pre-Tax Profit Up 114%
This Aveluro analysis covers FRT on HOSE in the Retail sector. The classified event type is earnings beat, with positive sentiment and a deterministic market-impact score of 9.8/10. Aveluro classifies this story as a positive catalyst in the stock's news coverage. Source coverage came from CafeF - Thị trường chứng khoán, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
FPT Retail (HoSE: FRT) reported 9M2026 consolidated revenue of VND 48,273 billion, up 33% year on year, and consolidated pre-tax profit of VND 1,724 billion, up 114%, according to the company’s nine-month business results report. The Long Chau pharmacy and vaccination chain contributed 69% of consolidated revenue, while the FPT Shop electronics chain also grew, giving FRT a two-engine growth profile spanning retail and healthcare.
Key Facts
- 9M2026 consolidated revenue: VND 48,273 billion, +33% versus 9M2025.
- 9M2026 consolidated pre-tax profit: VND 1,724 billion, +114% year on year.
- Q3/2026 consolidated revenue grew 34% year on year, with contributions from both Long Chau and FPT Shop.
- Company-wide online revenue reached VND 8,283 billion, +29% year on year.
- Long Chau revenue: VND 33,408 billion, +35% year on year, equal to 69% of consolidated revenue.
- Long Chau average revenue per pharmacy: VND 1.3 billion per month over the nine months.
- Network at end-September 2026: 2,741 pharmacies and 244 vaccination centres, up 324 pharmacies and 21 centres since the start of the year.
- FRT closed at VND 147,700 on 29 October 2026.
What Happened
FPT Retail, formally Công ty Cổ phần Bán lẻ Kỹ thuật số FPT, published nine-month 2026 results showing growth at both of its retail formats. The company said Long Chau and FPT Shop each maintained growth while continuing to innovate in operations, expand product and service ranges, and improve customer experience. The report attributes the profit expansion to operating efficiency gains rather than to a single one-off item, though it does not break out the profit split between the two chains.
Long Chau remained the larger earnings engine. The pharmacy and vaccination network reached 2,741 pharmacies and 244 vaccination centres nationwide by the end of September, and the company highlighted service expansion beyond dispensing: a health screening programme with the Hội Thầy thuốc trẻ Việt Nam and 16 multinational pharmaceutical firms, the first pharmacy on Côn Đảo, and a digital health partnership with Hồ Chí Minh City. Under that partnership, Long Chau is the sole healthcare partner in the city’s Trạm Công dân số programme, targeting 168 stations by the end of Q2/2027, with the “Ví khỏe nhà ta” utility recording more than 200,000 registered family accounts. The filing does not disclose the transaction value or investment cost of these initiatives.
Market Context
FRT trades on the Ho Chi Minh City Stock Exchange (HOSE) and closed at VND 147,700 on 29 October 2026. The stock sits at the intersection of two sectors: discretionary electronics retail through FPT Shop, which is sensitive to consumer demand and product cycles, and pharmacy-led healthcare retail through Long Chau, which carries steadier recurring demand. The 114% pre-tax profit growth materially outpaces the 33% revenue growth, pointing to operating leverage as the pharmacy network matures. The nine-month report does not provide a full-year guidance figure, so the results should be read against the company’s own prior disclosures rather than a stated target.
Strategic Significance
The investment case for FRT increasingly rests on Long Chau rather than on electronics retail. At 69% of consolidated revenue and growing 35% year on year, the pharmacy chain has become the primary driver of both scale and margin, while FPT Shop supplies cash flow and customer data. The vaccination centres and the Hồ Chí Minh City digital health partnership are attempts to move Long Chau from a dispensing business toward a broader primary-care touchpoint, which would raise revenue per store and deepen the moat against conventional pharmacy competitors. The key risk embedded in the numbers is that profit growth of 114% is flattered by a low base and by store maturation; sustaining it requires the newer cohorts of pharmacies to reach the VND 1.3 billion monthly average without eroding margins.
What to Watch
- Q3/2026 standalone profit breakdown between Long Chau and FPT Shop, if disclosed in the full financial statements.
- Store opening pace in Q4/2026 versus the 324 pharmacies added in the first nine months.
- Progress on the Hồ Chí Minh City Trạm Công dân số rollout toward the 168-station target by end-Q2/2027.
- Any full-year 2026 revenue and profit guidance issued alongside the annual general meeting or investor update.
- Foreign-ownership and institutional flow data for FRT on HOSE following the results.